Trials / Completed
CompletedNCT01192919
Tumour Registry Lung Cancer (TLK)
Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,500 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Overview of treatment reality in patients with bronchial carcinoma requiring systemic treatment and being treated by office-based oncologists in Germany.
Detailed description
The TLK is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with NSCLC and SCLC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.
Conditions
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2010-09-01
- Last updated
- 2020-03-02
Source: ClinicalTrials.gov record NCT01192919. Inclusion in this directory is not an endorsement.